InsidersTradesSigma
Track the APOGEE THERAPEUTICS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: CARL DAMBKOWSKI. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
APOGEE THERAPEUTICS INC is a company focused on developing innovative therapeutic treatments. It is listed on NASDAQ under the ticker XNAS.